Injection of G-CSF during leukaphereses reduces the number of aphereses needed for mobilization in unrelated hematopoietic stem cell donors

Ann Transplant. 2014 Sep 5:19:444-6. doi: 10.12659/AOT.890903.

Abstract

Background: This is a single-center, retrospective study in the field of mobilization of hematopoietic stem cell from unrelated donors. We aimed to investigate whether delaying the last G-CSF dose after the start of apheresis influences its results.

Material and methods: The medical records of 55 unrelated hematopoietic stem cell donors during the period 2010-2013 were analysed. In this series, 40 received donors the last G-CSF injection prior to the leukapheresis procedure, and 15 received the last injection after apheresis was initiated.

Results: In the delayed G-CSF application group, more donors had already reached the requested cell number during first apheresis than in the group treated following the standard procedure (73% vs. 35%, respectively; p<0.01). Also, the average total G-CSF dose needed to mobilize the requested cell number was lower (41 µg/kg vs. 48 µg/kg, respectively, p=0.002).

Conclusions: Delayed G-CSF use in donors undergoing stem cell mobilization shows a better efficiency of stem cell mobilization.

MeSH terms

  • Adult
  • Cell Count
  • Drug Administration Schedule
  • Female
  • Granulocyte Colony-Stimulating Factor / administration & dosage*
  • Hematopoietic Stem Cell Mobilization / methods*
  • Hematopoietic Stem Cell Transplantation*
  • Hematopoietic Stem Cells / cytology*
  • Humans
  • Injections
  • Lenograstim
  • Leukapheresis / methods*
  • Male
  • Middle Aged
  • Recombinant Proteins / administration & dosage
  • Retrospective Studies
  • Unrelated Donors
  • Young Adult

Substances

  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • Lenograstim